SEYED EBRAHIM KASSAIAN to Risk Assessment
This is a "connection" page, showing publications SEYED EBRAHIM KASSAIAN has written about Risk Assessment.
Connection Strength
0.206
-
The Association Between Modified Intracoronary Thrombus Grade and Cardiovascular Risk Factors and Initial Laboratory Findings in Patients Undergoing Primary Percutaneous Coronary Intervention. Crit Pathw Cardiol. 2019 09; 18(3):135-138.
Score: 0.077
-
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol. 2012 Jul 17; 11:82.
Score: 0.047
-
Immune checkpoint inhibitor-associated myocarditis: a novel risk score. Eur Heart J. 2026 Mar 05; 47(9):1050-1062.
Score: 0.030
-
Predictors of Long-term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly. Arch Iran Med. 2018 08 01; 21(8):344-348.
Score: 0.018
-
Percutaneous coronary intervention to treat chronic total occlusion: predictors of technical success and one-year clinical outcome. Tex Heart Inst J. 2014 Feb; 41(1):40-7.
Score: 0.013
-
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Tex Heart Inst J. 2012; 39(1):24-9.
Score: 0.011
-
In-hospital and mid-term adverse clinical outcomes of a direct stenting strategy versus stenting after pre-dilatation for the treatment of coronary artery lesions. Cardiovasc J Afr. 2008 Nov-Dec; 19(6):297-302.
Score: 0.009